KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xylem (XYL) EBT Margin (2016 - 2025)

Historic EBT Margin for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to 13.1%.

  • Xylem's EBT Margin rose 3100.0% to 13.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.36%, marking a year-over-year increase of 24100.0%. This contributed to the annual value of 12.7% for FY2024, which is 40700.0% up from last year.
  • Per Xylem's latest filing, its EBT Margin stood at 13.1% for Q3 2025, which was up 3100.0% from 12.99% recorded in Q2 2025.
  • In the past 5 years, Xylem's EBT Margin registered a high of 16.62% during Q4 2024, and its lowest value of 1.23% during Q3 2022.
  • In the last 5 years, Xylem's EBT Margin had a median value of 9.97% in 2022 and averaged 10.1%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -92800bps in 2022, then skyrocketed by 76800bps in 2023.
  • Over the past 5 years, Xylem's EBT Margin (Quarter) stood at 9.52% in 2021, then skyrocketed by 32bps to 12.55% in 2022, then decreased by -21bps to 9.92% in 2023, then surged by 68bps to 16.62% in 2024, then dropped by -21bps to 13.1% in 2025.
  • Its last three reported values are 13.1% in Q3 2025, 12.99% for Q2 2025, and 10.49% during Q1 2025.